T2 Biosystems, Inc. Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2024-09-30..
Quick ratio
Overview →Financial period ending 2024-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2024-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 24.43M USD | Liabilities, Current |
| Cash and equivalents | 2.08M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 2.03M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 3.83M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | (m) | $24.43M | $2.08M | (m) | $2.03M | $3.83M | (m) |
| 2024-06-30 | (m) | $21.80M | $4.25M | (m) | $1.30M | $5.17M | (m) |
| 2024-03-31 | (m) | $56.26M | $6.21M | (m) | $1.59M | $4.67M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2023-09-30 | (m) | $55.45M | (m) | (m) | $1.14M | $4.28M | (m) |
| 2023-06-30 | (m) | $66.06M | (m) | (m) | $1.35M | $4.34M | (m) |
| 2023-03-31 | (m) | $17.83M | (m) | (m) | $1.32M | $4.94M | (m) |
| 2022-12-31 | $12.49M | $10.13M | $10.33M | $0.00 | $2.16M | $4.29M | 1.23× |
| 2022-09-30 | (m) | $10.94M | (m) | $0.00 | $1.58M | $4.24M | (m) |
| 2022-06-30 | (m) | $13.19M | (m) | $0.00 | $2.72M | $5.67M | (m) |
| 2022-03-31 | (m) | $12.67M | (m) | $9.99M | $4.36M | $5.17M | (m) |
| 2021-12-31 | $37.38M | $11.69M | $22.25M | $10.00M | $5.13M | $3.91M | 3.20× |
| 2021-09-30 | (m) | $11.40M | (m) | $20.04M | $4.22M | $4.82M | (m) |
| 2021-06-30 | (m) | $9.35M | (m) | $20.08M | $3.98M | $4.78M | (m) |
| 2021-03-31 | (m) | $10.40M | (m) | $22.62M | $4.03M | $4.53M | (m) |
| 2020-12-31 | $47.29M | $9.80M | $16.79M | $25.40M | $5.10M | $3.64M | 4.83× |
| 2020-09-30 | (m) | $10.35M | (m) | $21.99M | $3.86M | $3.57M | (m) |
| 2020-06-30 | $37.10M | $7.95M | $26.55M | $9.25M | $1.30M | $4.11M | 4.67× |
| 2020-03-31 | (m) | $57.67M | $36.32M | (m) | $2.45M | $3.27M | (m) |
| 2019-12-31 | (m) | $60.57M | $11.03M | (m) | $2.83M | $3.60M | (m) |
| 2019-09-30 | (m) | $57.70M | $16.21M | (m) | $1.57M | $4.11M | (m) |
| 2019-06-30 | (m) | $57.80M | $28.42M | (m) | $1.18M | $3.10M | (m) |
| 2019-03-31 | (m) | $53.73M | $37.40M | (m) | $1.77M | $2.66M | (m) |
| 2018-12-31 | (m) | $52.30M | $50.80M | (m) | $1.79M | $2.68M | (m) |
| 2018-09-30 | (m) | $9.40M | $60.23M | (m) | $1.73M | $3.34M | (m) |
| 2018-06-30 | (m) | $10.31M | $70.71M | (m) | $1.59M | $2.16M | (m) |
| 2018-03-31 | (m) | $50.92M | $29.73M | (m) | $582.00K | $2.08M | (m) |
| 2017-12-31 | (m) | $51.78M | (m) | (m) | $467.00K | $1.34M | (m) |
| 2017-09-30 | (m) | $10.24M | $52.90M | (m) | $442.00K | $1.25M | (m) |
| 2017-06-30 | (m) | $10.47M | $46.13M | (m) | $981.00K | $1.01M | (m) |
| 2017-03-31 | (m) | $8.91M | $58.82M | (m) | $409.00K | $489.00K | (m) |
| 2016-12-31 | (m) | $9.88M | $73.49M | (m) | $327.00K | $803.00K | (m) |
| 2016-09-30 | (m) | $18.54M | (m) | (m) | $379.00K | $1.34M | (m) |
| 2016-06-30 | (m) | $17.48M | (m) | (m) | $288.00K | $1.44M | (m) |
| 2016-03-31 | (m) | $14.72M | (m) | (m) | $360.00K | $1.26M | (m) |
| 2015-12-31 | (m) | $12.25M | (m) | (m) | $369.00K | $683.00K | (m) |
| 2015-09-30 | (m) | $8.45M | (m) | (m) | $378.00K | $1.06M | (m) |
| 2015-06-30 | (m) | $7.69M | (m) | (m) | $389.00K | $569.00K | (m) |
| 2015-03-31 | (m) | $7.46M | (m) | (m) | $88.00K | $252.00K | (m) |
| 2014-12-31 | (m) | $5.17M | (m) | (m) | $201.00K | $115.00K | (m) |
| 2014-09-30 | (m) | $6.66M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $6.75M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | $23.70M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $4.05M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | $35.22M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $40.58M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $9.71M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $18.74M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.